Gene expression profiles reflect sclerosing cholangitis activity in abcb4 (−/−) mice

References

• Fickert P, Zollner G, Fuchsbichler A, Stumptner C, Weiglein AH, Lammert F, et al. Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. Gastroenterology 2002; 123: 1238–51
   PubMed Web of Science ®Google Scholar
• Popov Y, Patsenker E, Fickert P, Trauner M, Schuppan D. Mdr2 (Abcb4)−/− mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes. J Hepatol 2005; 43: 1045–54
   PubMed Web of Science ®Google Scholar
• Fickert P, Wagner M, Marschall HU, Fuchsbichler A, Zollner G, Tsybrovskyy O, et al. 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology 2006; 130: 465–81
   PubMed Web of Science ®Google Scholar
• Henkel C, Roderfeld M, Weiskirchen R, Berres ML, Hillebrandt S, Lammert F, et al. Changes of the hepatic proteome in murine models for toxically induced fibrogenesis and sclerosing cholangitis. Proteomics 2006; 6: 6538–48
   PubMed Web of Science ®Google Scholar
• Baghdasaryan A, Fickert P, Fuchsbichler A, Silbert D, Gumhold J, Horl G, et al. Role of hepatic phospholipids in development of liver injury in Mdr2 (Abcb4) knockout mice. Liver Int 2008; 28: 948–58
   PubMed Web of Science ®Google Scholar
• Mauad TH, Van Nieuwkerk CM, Dingemans KP, Smit JJ, Schinkel AH, Notenboom RG, et al. Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis. Am J Pathol 1994; 145: 1237–45
   PubMed Web of Science ®Google Scholar
• Fickert P, Fuchsbichler A, Wagner M, Zollner G, Kaser A, Tilg H., et al. Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology 2004; 127: 261–74
   PubMed Web of Science ®Google Scholar
• Hui AY, Friedman SL. Molecular basis of hepatic fibrosis. Expert Rev Molecular Med 2003; 5: 1–23
   PubMedGoogle Scholar
• Nakken KE, Nygard S, Haaland T, Berge KE, Arnkvaern K, Odegaard A, et al. Multiple inflammatory-, tissue remodelling- and fibrosis genes are differentially transcribed in the livers of Abcb4 (−/−) mice harbouring chronic cholangitis. Scand J Gastroenterol 2007; 42: 1245–55
   PubMed Web of Science ®Google Scholar
• Van Nieuwkerk CM, Elferink RP, Groen AK, Ottenhoff R, Tytgat GN, Dingemans KP, et al. Effects of ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene. Gastroenterology 1996; 111: 165–71
   PubMed Web of Science ®Google Scholar
• van Eyken P, Sciot R, van Damme B, de Wolf-Peeters C, Desmet VJ. Keratin immunohistochemistry in normal human liver. Cytokeratin pattern of hepatocytes, bile ducts and acinar gradient. Virchows Archiv-A (Pathol Anat Histopathol) 1987; 412: 63–72
   PubMedGoogle Scholar
• Snedecor GW, Cochran WG. Statistical methods6th ed. Iowa State University Press, IowaUSA 1971
   Google Scholar
• Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116–21
   PubMed Web of Science ®Google Scholar
• Hellerbrand C, Jobin C, Licato LL, Sartor RB, Brenner DA. Cytokines induce NF-kappaB in activated but not in quiescent rat hepatic stellate cells. Am J Physiol 1998; 275: 269–78
   PubMedGoogle Scholar
• Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000; 275: 2247–50
   PubMed Web of Science ®Google Scholar
• Pinzani M, Gesualdo L, Sabbah GM, Abboud HE. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest 1989; 84: 1786–93
   PubMed Web of Science ®Google Scholar
• Melton AC, Soon RK, Jr, Park JG, Martinez L, Dehart GW, Yee HF, Jr. Focal adhesion disassembly is an essential early event in hepatic stellate cell chemotaxis. Am J Physiol 2007; 293: G1272–80
   Google Scholar
• Knittel T, Schuppan D, Meyer zum Buschenfelde KH, Ramadori G. Differential expression of collagen types I, III, and IV by fat-storing (Ito) cells in vitro. Gastroenterology 1992; 102: 1724–35
   PubMed Web of Science ®Google Scholar
• Parsons CJ, Bradford BU, Pan CQ, Cheung E, Schauer M, Knorr A., et al. Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats. Hepatology 2004; 40: 1106–15
   PubMed Web of Science ®Google Scholar
• Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008; 88: 125–72
   PubMed Web of Science ®Google Scholar
• Grande JP. Role of transforming growth factor-beta in tissue injury and repair. Proc Soc Exp Biol Med 1997; 214: 27–40
   PubMed Web of Science ®Google Scholar
• Prud'homme GJ. Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations. Lab Invest 2007; 87: 1077–91
   PubMed Web of Science ®Google Scholar
• Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annua Rev Immunol 1998; 16: 137–161
   PubMed Web of Science ®Google Scholar
• Friedrichsen S, Heuer H, Christ S, Cuthill D, Bauer K, Raivich G. Gene expression of connective tissue growth factor in adult mouse. Growth Factors 2005; 23: 43–53
   PubMed Web of Science ®Google Scholar
• Grotendorst GR. Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev 1997; 8: 171–9
   PubMedGoogle Scholar
• Grotendorst GR, Okochi H, Hayashi N. A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ 1996; 7: 469–80
   PubMedGoogle Scholar